Trial intelligence / Profile preview

PDGF versus saline for healing of dental extraction sockets

ACTRN12626000228381Phase 4Not yet recruiting

Sponsor
University of Melbourne
Start
Apr 2026
Countries
1
01

Overview

Phase 4, randomised, open-label trial of platelet-derived growth factor in extraction socket healing (2 arms), sponsored by University of Melbourne. Primary endpoints: Changes in jawbone dimension at the extraction site and Amount of new bone formation at the extraction site. Planned start Apr 2026; status: not yet recruiting.

02

Drugs

platelet-derived growth factor
03

Conditions

extraction socket healing

Beyond the preview

Go deeper on ACTRN12626000228381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12626000228381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call